SYNSORYBIO

synsorybio-logo

SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services.

#People #Financial #Website #More

SYNSORYBIO

Social Links:

Industry:
Biotechnology Life Science Product Research

Founded:
2023-01-01

Address:
Somerville, Massachusetts, United States

Country:
United States

Website Url:
http://www.synsorybio.com

Total Employee:
1+

Status:
Active

Total Funding:
500 K USD


Founder


elliot-tague_image

Elliot Tague

nathan-tague_image

Nathan Tague

Investors List

y-combinator_image

Y Combinator

Y Combinator investment in Pre Seed Round - SynsoryBio

Official Site Inspections

http://www.synsorybio.com

  • Host name: 162.255.119.186
  • IP address: 162.255.119.186
  • Location: Los Angeles United States
  • Latitude: 34.0318
  • Longitude: -118.4252
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90064

Loading ...

More informations about "SynsoryBio"

SynsoryBio - Crunchbase Company Profile & Funding

SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services.See details»

SynsoryBio - LinkedIn

SynsoryBio has been awarded a National Science Foundation SBIR Phase I grant! We are honored to be supported by the NSF. With this award, we will continue to build the future of โ€ฆSee details»

SynsoryBio - Y Combinator

SynsoryBio was founded by brother scientists, Elliot and Nathan, who both hold PhDs in biomedical engineering. The founders gained expertise in synthetic biology at Boston โ€ฆSee details»

SynsoryBio 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for SynsoryBio. Use the PitchBook Platform to explore the full profile.See details»

Home [www.synsorybio.com]

More info coming soonSee details»

SynsoryBio - 2025 Company Profile, Funding & Competitors - Tracxn

May 6, 2025 SynsoryBio is a seed company based in Cambridge (United States), founded in 2023 by Elliot Tague and Nathan Tague. It operates as a Developer of protein therapeutics for โ€ฆSee details»

SYNSORYBIO, INC. - National Science Foundation

Dive into the research topics where SYNSORYBIO, INC. is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.See details»

SynsoryBio | protein therapeutics, cancer treatment, Zoonop

Overview SynsoryBio is a cutting-edge biotechnology company that focuses on developing next-generation protein therapeutics, particularly for cancer and autoimmune diseases. Founded in โ€ฆSee details»

SynsoryBio - Products, Competitors, Financials, Employees, โ€ฆ

SynsoryBio Frequently Asked Questions (FAQ) When was SynsoryBio founded? SynsoryBio was founded in 2023. Where is SynsoryBio's headquarters? SynsoryBio's headquarters is located โ€ฆSee details»

SynsoryBio - VentureRadar

SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the โ€ฆSee details»

Launch YC: SynsoryBio: Therapeutics that sense-and-respond to โ€ฆ

SynsoryBio (YC W24) is making protein therapeutics that sense-and-respond to disease, meaning their medicines will sense where they are in the body and conditionally activate at the diseased ...See details»

Elliot Tague (SynsoryBio): 10 Key Things You Must Know

Elliot Tague (SynsoryBio): 10 Key Things You Must Know: ### Overview Elliot Tague is a prominent figure in the field of biotechnology, known for his pioneering work in synthetic โ€ฆSee details»

» AlphaFund

May 7, 2024 AlphaFund: Welcome, Dr. Stephanie Johnson, CEO of SynsoryBio. Weโ€™re thrilled to have you here today to discuss your companyโ€™s groundbreaking work in the field of sensory โ€ฆSee details»

SynsoryBio - Funding, Financials, Valuation & Investors

SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services.See details»

SynsoryBio posted on LinkedIn

At SynsoryBio, they engineer "if-then" conditional logic into protein medicines, meaning only if the protein drug senses a disease marker, then it turns on.See details»

Pre Seed Round - SynsoryBio - 2024-04-03 - Crunchbase

Apr 3, 2024 SynsoryBio raised $500000 on 2024-04-03 in Pre Seed RoundSee details»

SynsoryBio on LinkedIn: SynsoryBio has been awarded a National โ€ฆ

SynsoryBio has been awarded a National Science Foundation SBIR Phase I grant! We are honored to be supported by the NSF. With this award, we will continue toโ€ฆSee details»

Nathan Tague (SynsoryBio): 10 Key Things You Must Know

1. Founding of SynsoryBio Nathan Tague co-founded SynsoryBio in 2023 alongside his brother Elliot Tague. The company is located in Cambridge, MA, and was funded by the prestigious โ€ฆSee details»

SynsoryBio - Updates, News, Events, Signals & Triggers

Apr 3, 2024 SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services.See details»

Bayer Launches Centafore Imaging Core Lab to Support Imaging โ€ฆ

1 day ago Centafore is an Imaging Contract Research Organization (iCRO) that supports early research through phase IV trials and Software as a Medical Device (SaMD) development for โ€ฆSee details»

linkstock.net © 2022. All rights reserved